Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Pulmonary Congestion
Interventions
DEVICE

MRI

"Cardiac MRI for LVEF and segmentation.~* Phase-contrast MRI for CO in aorta and each pulmonary vein.~* DCE-MRI for bolus kinetic parameter analysis."

DRUG

Gd-CA

Bolus kinetic parameter analysis, different doses of Gd-CA (Dotarem by Guerbet) ranging between 0.1 and 0.5 mmol will be injected intravenously after dilution in 5 milliliter saline by an injector at a speed of 5 ml/s.

DEVICE

BIS ImpediMed™ SFB7

"BIS will be measured by Bio-impedance spectroscopy will be performed using ImpediMed™ SFB7 (ImpediMed Limited 2008).~Impedance will be measured continuously during the fluid challenge and for maximum 600 seconds before and after the fluid challenge.~Currents of different frequencies will be applied; the resulting voltage will be recorded, with a time resolution for the complete frequency span not lower than 2 seconds."

DEVICE

Autotransfusion Lympamat Digital Gradient system

Lympamat Digital Gradient system (Bosl, Aachen) inflatable leg compression trousers will induce an autotransfusion by compressing the legs with a maximum of 90 mmHg for a maximum of 300 seconds

Trial Locations (1)

4194 TR

Catharina Hospital Eindhoven, Eindhoven

All Listed Sponsors
lead

Catharina Ziekenhuis Eindhoven

OTHER

NCT02364193 - Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance | Biotech Hunter | Biotech Hunter